{
  "trial_id": "NCT00194961",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Chronic renal insufficiency as defined by the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS; estimated creatinine clearance < 75 ml/min/1.73 m2 by the Schwartz formula)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Tanner Stage I or II",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Unable or unwilling to adhere to the protocol",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Additional diagnoses that could impair responsiveness to GH, e.g. dwarfism syndromes or significant extra-renal organ disease, e.g. chronic liver disease, diabetes mellitus, AIDS",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has Paget's Disease of Bone and is starting Bisphosphonate therapy.",
  "_meta": {
    "topic_id": "40",
    "trial_id": "NCT00194961",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}